Unveiled threats: Iran's patient protesters

<p>Iran’s <a href="https://www.economist.com/middle-east-and-africa/2022/12/04/irans-rattled-government-may-be-backing-down?utm_campaign=a.io&amp;utm_medium=audio.podcast.np&amp;utm_source=theintelligence&amp;utm_content=discovery.content.anonymous.tr_shownotes_na-na_article&amp;utm_term=sa.listeners" rel="noopener noreferrer" target="_blank">protests</a> may have gone quiet for the moment, but that does not mean they’ve been defeated. Beneath a calmer surface, Iranians are seething and biding their time. India’s <a href="https://www.economist.com/business/2023/01/05/a-scandal-rocks-indias-pharmaceutical-industry?utm_campaign=a.io&amp;utm_medium=audio.podcast.np&amp;utm_source=theintelligence&amp;utm_content=discovery.content.anonymous.tr_shownotes_na-na_article&amp;utm_term=sa.listeners" rel="noopener noreferrer" target="_blank">pharma</a> sector is huge, but has long been dogged by concerns about quality control. And we reveal last year’s most <a href="https://www.economist.com/graphic-detail/2022/12/20/war-replaces-disease-as-the-worlds-most-newsworthy-subject?utm_campaign=a.io&amp;utm_medium=audio.podcast.np&amp;utm_source=theintelligence&amp;utm_content=discovery.content.anonymous.tr_shownotes_na-na_article&amp;utm_term=sa.listeners" rel="noopener noreferrer" target="_blank">newsworthy subject</a>.</p><p>For full access to print, digital and audio editions of <em>The Economist</em>, subscribe here <a href="http://www.economist.com/intelligenceoffer" rel="noopener noreferrer" target="_blank">www.economist.com/intelligenceoffer</a></p><hr /><p style="color: grey; font-size: 0.75em;"> Hosted on Acast. See <a href="https://acast.com/privacy" rel="noopener noreferrer" style="color: grey;" target="_blank">acast.com/privacy</a> for more information.</p>